You searched for metabolic diseases - Page 49 of 64

News and Trends 19 Oct 2017

Meet some of the Hottest Startups of 2017!

…covering neuroscience, oncology, cardiovascular and metabolic diseases, immunology, infectious diseases, vaccines and pulmonary hypertension. Chosen startups will have the opportunity to present their innovative ideas to a panel of expert…

October 19, 2017 - 7 minutesmins - By External Contributor

News and Trends 9 May 2017

AI-Based Drug Discovery Biotech is Recruited by Sanofi in €250M Deal

…believes using a bispecific drug approach that goes after more than one target can significantly increase the chances of success. Especially in metabolic diseases with high complexity such as diabetes….

May 9, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 10 Sep 2021

The Top European Biotech Funding Rounds in August

…metabolic diseases involving the liver. And NRG Therapeutics in the UK closed a small seed investment of around £490,000 (€570,000) in a bid to treat Parkinson’s disease. One interesting seed…

September 10, 2021 - 4 minutesmins - By Jonathan Smith

News and Trends 4 Oct 2022

TrialSpark partners with Sanofi to acquire and develop clinical-stage novel therapies

…aspects of clinical drug development. It acquires clinical-stage drugs from pharmaceutical and biotech companies and develops them. TrialSpark’s current therapeutic areas of focus include rheumatology, dermatology, CNS, and cardiometabolic diseases….

October 4, 2022 - 2 minutesmins - By Jim Cornall

In Depth 5 Dec 2024

The biggest private biotech investments in November 2024

…million in series B funding. The company is focused on advancing the next generation of therapies for obesity and metabolic diseases, and the proceeds from this financing round will go…

December 5, 2024 - 3 minutesmins - By Willow Shah-Neville

News and Trends 11 Jul 2022

Treatment for cancer-associated thrombosis fast-tracked by FDA

A clinical-stage biotechnology company that develops therapies for cardiovascular and metabolic diseases today (July 11) announced it has been granted fast track designation by the US Food and Drug Administration…

July 11, 2022 - 4 minutesmins - By Liza Laws

News and Trends 2 Dec 2016

Better than ADCs? AstraZeneca bids for Bicyclic Peptides

…peptides, hence the company’s name, has lured AstraZeneca into offering over €1B for the development of drug candidates for respiratory, cardiovascular and metabolic diseases. Bicycles, the bicyclic peptides developed at…

December 2, 2016 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 10 Nov 2016

This has been the Worst Financial Year for Biotech in a Decade

A presentation on the financial state of biotech kicked off BIO-Europe in Cologne this week. The hostile American political climate has done some damage. There’s a political storm brewing across…

November 10, 2016 - 4 minutesmins - By Evelyn Warner

News and Trends 1 Nov 2022

J.P. Morgan launches life sciences private capital team

…diseases, autoimmunity, AI/ML platforms, metabolic diseases and neuropsychology. The new team sits within J.P. Morgan Private Capital, a growth equity and private credit investment platform. The platform finances private companies…

November 1, 2022 - 2 minutesmins - By Jim Cornall

More News! 10 Dec 2024

Biotech in 2024: A retrospective

…a potential paradigm shift in treatment, especially given its convenient oral administration. Jeremy Levin, CEO of Ovid Therapeutics, compares the rising success of GLP-1 therapies in cardiometabolic diseases to the…

December 10, 2024 - 14 minutesmins - By Jules Adam

News and Trends 22 Nov 2022

Arecor to start second type 2 diabetes clinical trial

…trial will be conducted at the Medical University of Graz, Austria, a research facility in metabolic diseases research and euglycemic clamp methodology, with Thomas Pieber as the trial’s principal investigator….

November 22, 2022 - 3 minutesmins - By Jim Cornall

Interview 26 Feb 2018

This Biotech Could Replace Opioids with Safe and Effective Pain Relief for Osteoarthritis

…of drug discovery [and] different departments ranging from urology to metabolic diseases, and then later on working in the pain area,” Westbrook told me. During his time there, he came…

February 26, 2018 - 9 minutesmins - By Alex Dale

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: metabolic diseases

Meet some of the Hottest Startups of 2017!

AI-Based Drug Discovery Biotech is Recruited by Sanofi in €250M Deal

The Top European Biotech Funding Rounds in August

TrialSpark partners with Sanofi to acquire and develop clinical-stage novel therapies

The biggest private biotech investments in November 2024

Treatment for cancer-associated thrombosis fast-tracked by FDA

Better than ADCs? AstraZeneca bids for Bicyclic Peptides

This has been the Worst Financial Year for Biotech in a Decade

J.P. Morgan launches life sciences private capital team

Biotech in 2024: A retrospective

Arecor to start second type 2 diabetes clinical trial

This Biotech Could Replace Opioids with Safe and Effective Pain Relief for Osteoarthritis

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!